ALA 1.35% 18.3¢ arovella therapeutics limited

broker valuation of 17c, page-20

  1. 7,366 Posts.
    lightbulb Created with Sketch. 295
    Clyde, I'm sure I'm reading it right, as the valuation chart shows a 2 & 5c valuation per share, or $70m for both. However I don't really think their valuation really matters, because at the end of the day it will come down to negotiations and the number of parties interested in the products.

    I also want to point out a couple of other things about the report:

    1 - Westcoast - I keep harping on about the importance of WC, and this report confirms it. Note that the revenue for 2014 is forecasted at $10m which should see the company turn a maiden profit. In 2015 the revenue grows to $42m and a huge profit of $25m.

    Although the report states that there should be no CR's in the near future, I'm thinking we may not need a CR ever if WC can generate these figures.

    2 - Small company reports such as this one are normally instigated by the company to pump their share price for a CR. We're cashed up and in no need of a CR. So it's pleasing to see that this is a genuine report instigated by a broker for their members.
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
18.3¢
Change
-0.003(1.35%)
Mkt cap ! $195.4M
Open High Low Value Volume
18.5¢ 18.5¢ 18.3¢ $66.27K 358.5K

Buyers (Bids)

No. Vol. Price($)
10 650427 18.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.5¢ 103209 4
View Market Depth
Last trade - 13.16pm 05/11/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.